Bionano Genomics, Inc. (BNGO) Shareholders’ equity 2017–2025
Bionano Genomics, Inc. (BNGO) shareholders’ equity at each fiscal year-end, per SEC filings.
$44.4MFY2025 · since FY2017: -$50.2M → $44.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $44.4M | +25.6% |
| FY2024 | $35.4M | -63.2% |
| FY2023 | $96.2M | -61.4% |
| FY2022 | $249.4M | -26.0% |
| FY2021 | $337.1M | +860.9% |
| FY2020 | $35.1M | +871.0% |
| FY2019 | $3.6M | -64.4% |
| FY2018 | $10.1M | +120.2% |
| FY2017 | -$50.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice